Surgery in patients with congenital factor VII deficiency - a single center study

Journal Title: Polish Journal of Surgery - Year 2018, Vol 90, Issue 5

Abstract

Introduction: Congenital factor VII deficiency is a rare hemorrhagic disorder inherited in an autosomal recessive pattern. Surgical treatment with insufficient diathesis correction is burdened with high risk of bleeding complications. The aim of the study was evaluation of the surgical outcome in patients with congenital factor VII deficiency and assessment of the efficacy and safety of recombinant activated factor VII (rFVIIa) used for perioperative hemostatic coverage in our two schemas of substitutive therapy. Material and methods: In the years 2002-2017 a total of 22 patients with congenital factor VII deficiency were subjected to surgery. Substitution therapy relied on rFVIIa used in two schemas. One involved 15 patients with factor VII activity of<10% of normal value who were injected rFVIIa at a dose of 30 μg/kg b.w. every12 hours on surgery day, 15 μg/kg b.w. every 12 hours on the first postoperative day and 15 μg/kg b.w. every 24 hours on the following days. The second schema involved 7 patients with factor VII activity of 10-25% of normal value who were given rFVIIa at a dose of 15 μg/kg b.w. every 12 hours on surgery day and the first postoperative day; then the same dose was administered every 24 hours on consecutive days. The treatment continued for 4-10 days. Results: In the 22 patients a total of 26 surgeries were performed; 17 surgeries in 15 patients with factor VII<10% of normal and 9 in 7 patients with factor VII deficiency of 10-25% of normal. The surgeries included: 9 cholecystectomies (8 laparoscopic,1 open), 7 thyroidectomy procedures, 2 exploratory laparotomies, 1 left hemicolectomy, 1 total proctocolectomy, 3 inguinal hernia repairs and 3 excisions of varicose veins. One patient with factor VII activity of 9% required an additional dose of rFVIIa in the intraoperative period due to diathesis bleeding. Intraoperative hemostasis was normal for all other patients; no postoperative hemorrhagic complications were reported. In patients with FVII activity<10% average daily dose of rFVIIa was 31.3(range 20-56) μg/kg b.w., total daily dose 186(136-303) µg/kg b.w., total dose of rFVIIa-15.2(12-112) mg. In patients with FVII activity 10-25% the doses were 21.2(15-31), 117(46-271) µg/kg b.w. and 9.1(6-17) mg respectively. Conclusions: Surgery in patients with congenital factor VII deficiency can be safely and efficiently performed with rFVIIa as substitutive treatment securing perioperative hemostasis. <br/><br/>

Authors and Affiliations

Andrzej Szczepanik, Adam Wiszniewski, Anna Oses-Szczepanik, Wojciech Dąbrowski, Konrad Pielaciński

Keywords

Related Articles

Gruczolakotorbielak śluzowy wyrostka robaczkowego – opis przypadku

Nowotwory wyrostka robaczkowego należą do rzadkości i stanowią ok. 0,4% nowotworów przewodu pokarmowego. Wśród nich najczęściej występującym nowotworem łagodnym jest gruczolakotorbielak śluzowy. Występuje w 0,6% resekowa...

Czynniki ryzyka reoperacji w chirurgii kolorektalnej

Wstęp: Powtórne interwencje chirurgiczne po operacjach jelita grubego są najczęściej wynikiem poważnych powikłań pooperacyjnych. Wg niektórych badaczy, odsetek reoperacji może służyć jako wskaźnik oceny jakości leczenia...

Can the leukocyte`s parameters in peripheral blood smear predict the risk of in-hospital death of patients undergoing high-risk gastrointestinal surgery?

Introduction. White blood cell (WBC) count constitutes a part of routine peripheral blood examination (FBC, full blood count). Precise analysis of leukocytes’ parameters in blood smear is usually performed only when leuk...

Akceptacja choroby chorych na raka płuca przed i po zakończeniu leczenia chirurgicznego

Wprowadzenie: Rak płuca jest najczęstszym nowotworem złośliwym na świecie, a także jednym z najgorzej rokujących. Akceptacja choroby jest najważniejszym elementem w procesie przystosowania się do życia. Im wyższa, tym mn...

Download PDF file
  • EP ID EP346421
  • DOI 10.5604/01.3001.0012.0668
  • Views 88
  • Downloads 0

How To Cite

Andrzej Szczepanik, Adam Wiszniewski, Anna Oses-Szczepanik, Wojciech Dąbrowski, Konrad Pielaciński (2018). Surgery in patients with congenital factor VII deficiency - a single center study. Polish Journal of Surgery, 90(5), 1-5. https://europub.co.uk/articles/-A-346421